Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

NCT00254163 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

B-Cell Chronic Lymphocytic Leukemia

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Pentostatin

Sponsor

US Oncology Research

Collaborators

[object Object]